JC polyomavirus reactivation is not associated with herpes zoster

被引:0
|
作者
Jeong, B. H.
Park, S. J.
Koo, D. W.
Kim, Y. S. [1 ]
机构
[1] Hallym Univ, Ilsong Inst Life Sci, Anyang 431060, South Korea
[2] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, South Korea
[3] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Dermatol, Chunchon, South Korea
[4] Eulji Univ, Coll Med, Dept Dermatol, Taejon, South Korea
关键词
JC polyomavirus; genotype; herpes zoster; Varicella-zoster virus; virus reactivation; phylogenetic analysis;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Herpes zoster (HZ) is a neurocutaneous disease caused by Varicella-zoster virus (VZV) as a consequence of declined cell-mediated immunity, immune suppression and immunodeficiency. As reactivation of JC polyomavirus (JCPyV) might be linked with immunodeficiency or immuno suppressive therapy, the relationship between HZ and JCPyV reactivation was investigated. The incidence of JCPyV in urine samples from 102 patients with HZ and 100 healthy individuals from South Korea was determined by PCR. The incidence values for HZ patients and control individuals did not differ significantly (24.5% vs. 20.0%, respectively, P = 0.5391). When different age groups were monitored, the positivity values of 21.1%, 20.0%, and 30% were found for 20-39, 40-59 and over 60 year-old patients, respectively. In order to determine the genotype of JCPyV isolates, their VPI-large T antigen (VT)-intergenic region was PCR amplified, sequenced and analyzed. Three distinct types, namely 1, 2A and 7B were found in 8%, 24%, and 68% of were found among 25 isolates from HZ patients. Using phylogenetic analysis, the type 1 isolates were assigned to the IC subtype. These results indicate that HZ does not play an important role in JCPyV reactivation and is not associated with JCPyV.
引用
收藏
页码:121 / 128
页数:8
相关论文
共 50 条
  • [41] Concurrent Reactivation of Herpes Simplex and Varicella Zoster Viruses Confirmed by the Loop-Mediated Isothermal Amplification Assay
    Kobayashi, Tsukane
    Yagami, Akiko
    Suzuki, Kayoko
    Yoshikawa, Tetsushi
    Matsunaga, Kayoko
    CASE REPORTS IN DERMATOLOGY, 2014, 6 (01): : 5 - 9
  • [42] Laboratory diagnosis of herpes zoster
    Sauerbrei, A
    Eichhorn, U
    Schacke, M
    Wutzler, P
    JOURNAL OF CLINICAL VIROLOGY, 1999, 14 (01) : 31 - 36
  • [43] Immunity and the Burden of Herpes Zoster
    Choi, Won Suk
    Kwon, Soon Sun
    Lee, Jacob
    Choi, Su-Mi
    Lee, Jin Soo
    Eom, Joong Sik
    Sohn, Jang Wook
    Choeng, Hee Jin
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (03) : 525 - 530
  • [44] Virological diagnosis of herpes zoster
    Sauerbrei, A
    Sommer, M
    Wutzler, P
    HAUTARZT, 1999, 50 (12): : 873 - 878
  • [45] Prevention of herpes zoster in the elderly
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (600): : 12 - 13
  • [46] Variations in herpes zoster manifestation
    Wollina, Uwe
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 294 - 298
  • [47] Complications of Varicella Zoster Virus Reactivation
    Nagel, Maria A.
    Gilden, Don
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2013, 15 (04) : 439 - 453
  • [48] Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal
    Shah, Sangam
    Baral, Bikash
    Chamlagain, Rajan
    Murarka, Hritik
    Adhikari, Yagya Raj
    Paudel, Basanta Sharma
    CLINICAL CASE REPORTS, 2021, 9 (12):
  • [49] Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Glass, Jacob L.
    Derkach, Andriy
    Hilden, Patrick
    King, Amber
    Seo, Susan K.
    Ahr, Katya
    Kishtagari, Ashwin
    Levine, Ross L.
    Tallman, Martin S.
    Douer, Dan
    LEUKEMIA RESEARCH, 2021, 106
  • [50] Complications of Varicella Zoster Virus Reactivation
    Maria A. Nagel
    Don Gilden
    Current Treatment Options in Neurology, 2013, 15 : 439 - 453